Filing Flows › Biotricity (BTCY) › Q2 FY26
Biotricity (BTCY) Q2 FY26 earnings results (second quarter fiscal 2026)
10-Q filed Nov 14, 2025
Biotricity (BTCY) reported revenue of $3.9M for the second quarter fiscal 2026 (Q2 FY26), +19% from a year earlier and +0.3% from the quarter before. Operating margin was 7.0%, net loss $691K (17.8% of revenue).
Biotricity, Q2 FY26: revenue $3.9M (+19% year over year), operating margin 7.0%, net loss $691K, operating cash flow $416K. The chart follows the revenue to costs, profit and cash.
| Q2 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.9M | +0.3% | +19% |
| Operating profit | $274K | -3% | — |
| Net earnings | −$691K | — | — |
| Operating cash flow | $416K | — | — |
What changed
Revenue was $3.9M in Q2 FY26, up 19% year over year and roughly flat from the previous quarter. Technology Fees was the largest line at 90% of revenue. Technology Fees added $447K year over year (up 15%), 72% of the total change.
Gross margin was 81.9%, up 6.6 points from a year earlier. Operating profit was $274K, a 7.0% margin (up 16.5 points year over year). Operating expenses grew 5% against revenue growth of 19%. The fastest-growing cost line was Research & development (+16%). The quarter ended with a net loss of $691K, wider than the previous quarter's $672K loss. Net interest and other expense of $1.0M was the main reason.
Operating cash flow was $416K. Non-cash charges added back $1K of depreciation and $6K of share-based compensation. Working capital and other items added $1.1M.
Questions
What was Biotricity's revenue in the second quarter fiscal 2026?
Biotricity (BTCY) reported revenue of $3.9M for the second quarter fiscal 2026 (Q2 FY26), +19% from a year earlier and +0.3% from the quarter before.
Was Biotricity profitable in the second quarter fiscal 2026?
Operating profit was $274K (7.0% of revenue) and net loss $691K.
Source: Biotricity 10-Q on SEC EDGAR.